These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19168109)

  • 1. Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine.
    Zhang J; Liu CB; Li RC; Li YM; Zheng YJ; Li YP; Luo D; Pan BB; Nong Y; Ge SX; Xiong JH; Shih JW; Ng MH; Xia NS
    Vaccine; 2009 Mar; 27(12):1869-74. PubMed ID: 19168109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and efficacy of a bacterially expressed HEV ORF3 peptide, assessed by experimental infection of primates.
    Ma H; Song X; Harrison TJ; Li R; Huang G; Zhang H; Kong W; Wang Y
    Arch Virol; 2009; 154(10):1641-8. PubMed ID: 19763777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of a recombinant hepatitis E vaccine HEV 239.
    Li SW; Zhao Q; Wu T; Chen S; Zhang J; Xia NS
    Hum Vaccin Immunother; 2015; 11(4):908-14. PubMed ID: 25714510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of a recombinant hepatitis E vaccine.
    Shrestha MP; Scott RM; Joshi DM; Mammen MP; Thapa GB; Thapa N; Myint KS; Fourneau M; Kuschner RA; Shrestha SK; David MP; Seriwatana J; Vaughn DW; Safary A; Endy TP; Innis BL
    N Engl J Med; 2007 Mar; 356(9):895-903. PubMed ID: 17329696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial.
    Zhu FC; Zhang J; Zhang XF; Zhou C; Wang ZZ; Huang SJ; Wang H; Yang CL; Jiang HM; Cai JP; Wang YJ; Ai X; Hu YM; Tang Q; Yao X; Yan Q; Xian YL; Wu T; Li YM; Miao J; Ng MH; Shih JW; Xia NS
    Lancet; 2010 Sep; 376(9744):895-902. PubMed ID: 20728932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice.
    Renoux VM; Fleury MJ; Bousarghin L; Gaitan J; Sizaret PY; Touzé A; Coursaget P
    Vaccine; 2008 Dec; 26(51):6602-7. PubMed ID: 18835319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroepidemiology and molecular characterization of hepatitis E virus in Jilin, China.
    Zhu G; Qu Y; Jin N; Sun Z; Liu T; Lee H; Tian M; Wang T
    Infection; 2008 Mar; 36(2):140-6. PubMed ID: 18330507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of cynomolgus monkeys against HEV infection by oral administration of recombinant hepatitis E virus-like particles.
    Li TC; Suzaki Y; Ami Y; Dhole TN; Miyamura T; Takeda N
    Vaccine; 2004 Jan; 22(3-4):370-7. PubMed ID: 14670318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates.
    Li SW; Zhang J; Li YM; Ou SH; Huang GY; He ZQ; Ge SX; Xian YL; Pang SQ; Ng MH; Xia NS
    Vaccine; 2005 Apr; 23(22):2893-901. PubMed ID: 15780738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenge studies in Rhesus monkeys immunized with candidate hepatitis E vaccines: DNA, DNA-prime-protein-boost and DNA-protein encapsulated in liposomes.
    Arankalle VA; Lole KS; Deshmukh TM; Srivastava S; Shaligram US
    Vaccine; 2009 Feb; 27(7):1032-9. PubMed ID: 19095027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of hepatitis E vaccine in elderly people older than 65 years.
    Yu XY; Chen ZP; Wang SY; Pan HR; Wang ZF; Zhang QF; Shen LZ; Zheng XP; Yan CF; Lu M; Chen B; Zheng Y; Zhang J; Lv HK; Huang SJ
    Vaccine; 2019 Jul; 37(32):4581-4586. PubMed ID: 31262585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The investigation of HEV epidemiology, inferior clinical infection and viral-toxemia in blood donors in Quzhou area].
    He XH; Lv H; Zhen JX; Zhu MX; Wang F
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Feb; 22(1):45-7. PubMed ID: 18414699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The first experimental study on a candidate combined vaccine against hepatitis A and hepatitis E.
    Dong C; Dai X; Meng JH
    Vaccine; 2007 Feb; 25(9):1662-8. PubMed ID: 17156900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis E: a neglected threat.
    Myint KS; Gibbons RV
    Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):211-2. PubMed ID: 17658568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroepidemiology of hepatitis E virus infection in 2-25-year-olds in Sari district, Islamic Republic of Iran.
    Saffar MJ; Farhadi R; Ajami A; Khalilian AR; Babamahmodi F; Saffar H
    East Mediterr Health J; 2009; 15(1):136-42. PubMed ID: 19469436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward the development of a hepatitis E vaccine.
    Kamili S
    Virus Res; 2011 Oct; 161(1):93-100. PubMed ID: 21620908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preliminary evidence that a hepatitis E virus (HEV) ORF2 recombinant protein protects cynomolgus macaques against challenge with wild-type HEV].
    Bi S; Lu J; Jiang L; Huang G; Pan H; Jiang Y; Zhang M; Shen X
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Mar; 16(1):31-2. PubMed ID: 11986741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity difference between two hepatitis E vaccines derived from genotype 1 and 4.
    Wen J; Behloul N; Dai X; Dong C; Liang J; Zhang M; Shi C; Meng J
    Antiviral Res; 2016 Apr; 128():36-42. PubMed ID: 26850829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibody detection of hepatitis E virus in some human population, swine and chicken in Beijing in China].
    Tian RG; Lu J; Zhang BC; Jiang YZ; Bi SL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Feb; 23(1):14-6. PubMed ID: 19799006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression, purification and immunogenicity of a novel hepatitis E virus-like particle].
    Dong C; Meng JH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 May; 22(3):339-42. PubMed ID: 16643795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.